Meta Cell Technology (MCT) has been featured in the Daily Mail, one of the United Kingdom’s most widely read national publications, following a first-person account by beauty journalist and author Alice Hart-Davis documenting her experience with an MCT-based treatment performed at a London aesthetic clinic.
The treatment was carried out by Dr Sophie Shotter at her Harley Street practice, a clinic known for its emphasis on clinical standards and evidence-based aesthetic medicine. In the United Kingdom, Beautyform Medical supports the presence of Meta Cell Technology within selected aesthetic settings where physician-led regenerative protocols are being incorporated into practice.
The cervical and submandibular region remains one of the most technically demanding areas in non-surgical aesthetic medicine. Differences in skin structure, tissue behaviour, and biomechanical stress mean that approaches commonly used in the face do not always translate predictably to the neck. For patients presenting with skin laxity, textural change, and reduced jawline definition, treatment options have historically been more limited and often less satisfactory.
The MCT System is designed to precondition autologous biological material through the combined application of controlled visible and near-infrared light (467–850 nm) and precisely regulated temperature parameters.
Within this platform, the MCT Exosomes protocol applies a defined blue-light preset at 467 nm together with a controlled 37°C temperature condition to support the endogenous release of naïve extracellular vesicles from the patient’s own platelet-derived material. These vesicles are associated with paracrine signalling processes that may contribute to cellular communication, local microenvironment modulation, and tissue-supportive regenerative pathways.
The Daily Mail feature brings broader public visibility to this evolving field through the perspective of a recognised beauty journalist undergoing treatment in a real clinical setting. For Meta Cell Technology, this type of editorial attention reflects the growing interest in non-surgical regenerative approaches that are grounded in autologous biology, controlled processing, and physician-led clinical application.
